Rofecoxib cyclooxygenase 2 inhibitors. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Gastric Mucosa Seminal Vesicles Endothelium, Vascular Blood Platelets Cells, Cultured Intestinal Mucosa Digestive System Aorta, Thoracic Gastrointestinal Tract Bile Stomach Microsomes Arterioles Gastric Acid Kidney Macrophages Muscle, Smooth, Vascular Mesenteric Arteries Cardiovascular System Cell Line Aorta Lung

Organisms9

Rats, Sprague-Dawley Rats, Wistar Sheep Rabbits Mice, Inbred C57BL Dogs Saimiri Mice, Knockout Gerbillinae

Diseases26

Osteoarthritis Gastrointestinal Diseases Stomach Ulcer Edema Peptic Ulcer Arthralgia Duodenal Obstruction Arthritis, Rheumatoid Osteoarthritis, Knee Gastric Outlet Obstruction Inflammation Cardiovascular Diseases Disease Models, Animal Colorectal Neoplasms Hyperalgesia Gastrointestinal Hemorrhage Arthritis Osteoarthritis, Hip Pain, Postoperative Thrombosis Adenoma Arthritis, Experimental Intestinal Perforation Migraine Disorders Myocardial Infarction Colonic Neoplasms

Chemicals and Drugs145

Lactones Cyclooxygenase Inhibitors Sulfones Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Cyclooxygenase 1 Prostaglandin-Endoperoxide Synthases Anti-Inflammatory Agents, Non-Steroidal Pyrazoles Indomethacin Dinoprostone Naproxen Ibuprofen Isoenzymes Sulfonamides Diclofenac Prostaglandins Membrane Proteins Thiazines Arachidonic Acid Aspirin Nitrobenzenes Thromboxane B2 Lipoxygenase Inhibitors Epoprostenol Arachidonic Acids Analgesics, Non-Narcotic Isodesmosine Receptors, Prostaglandin E Flurbiprofen Lipoxygenase 6-Ketoprostaglandin F1 alpha Eicosanoids Masoprocol Butanones Piroxicam Thromboxane A2 Intramolecular Oxidoreductases Acetaminophen Thromboxane-A Synthase Enzyme Inhibitors Arachidonate 5-Lipoxygenase Furans Thromboxanes Meclofenamic Acid Hydroxyeicosatetraenoic Acids Phenacetin Leukotriene B4 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid Prostaglandins G 5,8,11,14-Eicosatetraynoic Acid Dinoprost 2-Aminoadipic Acid Desmosine 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine Isoxazoles RNA, Messenger Prostaglandins E Nitric Oxide Elastin Nitric Oxide Synthase Phospholipases A Prostaglandin H2 Phospholipases A2 Sulindac Leukotrienes 8,11,14-Eicosatrienoic Acid Ketorolac Placebos Anti-Inflammatory Agents Arachidonate Lipoxygenases Thiazoles Receptors, Thromboxane Prostaglandin D2 Bradykinin Receptors, Prostaglandin E, EP4 Subtype Cytochrome P-450 CYP1A2 Receptors, Prostaglandin E, EP1 Subtype Prostaglandin Antagonists Arachidonate 15-Lipoxygenase Calcimycin Oxygen Isotopes Prostaglandins H Hydrazines Salicylates Tolmetin Chromium Radioisotopes NG-Nitroarginine Methyl Ester Receptors, Prostaglandin E, EP2 Subtype Interleukin-1 Lipopolysaccharides Nitric Oxide Synthase Type II Peroxidases Receptors, Prostaglandin Ketoprofen Ketorolac Tromethamine Nitroarginine Vasodilator Agents 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid Biological Factors SRS-A Receptors, Prostaglandin E, EP3 Subtype Acetylcholine Carbon Radioisotopes Vasoconstrictor Agents Receptors, Thromboxane A2, Prostaglandin H2 Quinacrine Aldehydes 1,2-Dimethylhydrazine Prostaglandins F Phospholipases A2, Cytosolic Hydroxyprostaglandin Dehydrogenases Lipoxins Fatty Acids, Unsaturated Dexamethasone Sodium Salicylate Free Radicals Arachidonate 12-Lipoxygenase NF-kappa B omega-N-Methylarginine Peroxides Group IV Phospholipases A2 Cytochrome P-450 Enzyme System Alprostadil Autacoids Prostaglandins I Tumor Necrosis Factor-alpha Linoleic Acid Nitroprusside Lipid Peroxides Indoprofen Isoprostanes Proadifen Eicosanoic Acids Anti-Ulcer Agents Prostaglandin Endoperoxides, Synthetic Endothelium-Dependent Relaxing Factors Receptors, Epoprostenol Delayed-Action Preparations Diflunisal Phospholipases Prostaglandins D Prostaglandin Endoperoxides Catechols Carrageenan

Analytical, Diagnostic and Therapeutic Techniques and Equipment27

Clinical Trials, Phase IV as Topic Double-Blind Method Adverse Drug Reaction Reporting Systems Early Termination of Clinical Trials Otorhinolaryngologic Surgical Procedures Placebos Product Surveillance, Postmarketing Chromatography, High Pressure Liquid Administration, Oral Pain Measurement Drug Prescriptions Disease Models, Animal Immunohistochemistry Drug Therapy, Combination Blotting, Western Blood Pressure Risk Factors Treatment Outcome Drug Administration Schedule Reverse Transcriptase Polymerase Chain Reaction Randomized Controlled Trials as Topic Arthritis, Experimental Cross-Over Studies Incidence Delayed-Action Preparations Injections, Subcutaneous Risk

Psychiatry and Psychology1

Phenomena and Processes21

Dose-Response Relationship, Drug Vasodilation Arthralgia Enzyme Induction Drug Interactions Gene Expression Regulation, Enzymologic Vasoconstriction Time Factors Platelet Aggregation Drug Synergism Blood Pressure Signal Transduction Arterial Pressure Kinetics Biotransformation Up-Regulation Tissue Distribution Enzyme Activation Risk Apoptosis Gene Expression

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

Safety-Based Drug Withdrawals Jurisprudence Legislation, Drug

Technology, Industry, Agriculture1

Information Science2

Adverse Drug Reaction Reporting Systems Incidence

Health Care17

Safety-Based Drug Withdrawals Clinical Trials, Phase IV as Topic Double-Blind Method Adverse Drug Reaction Reporting Systems Jurisprudence Early Termination of Clinical Trials Drug Utilization Review Drug Costs Drug Prescriptions Legislation, Drug Risk Factors Treatment Outcome Randomized Controlled Trials as Topic Cross-Over Studies Costs and Cost Analysis Incidence Risk

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care Geographicals

Lactones Cyclooxygenase Inhibitors Sulfones Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Cyclooxygenase 1 Prostaglandin-Endoperoxide Synthases Anti-Inflammatory Agents, Non-Steroidal Safety-Based Drug Withdrawals Pyrazoles Indomethacin Dinoprostone Naproxen Ibuprofen Isoenzymes Sulfonamides Diclofenac Prostaglandins Membrane Proteins Thiazines Arachidonic Acid Aspirin Clinical Trials, Phase IV as Topic Nitrobenzenes Thromboxane B2 Lipoxygenase Inhibitors Osteoarthritis Gastrointestinal Diseases Epoprostenol Arachidonic Acids Analgesics, Non-Narcotic Isodesmosine Receptors, Prostaglandin E Flurbiprofen Lipoxygenase Stomach Ulcer 6-Ketoprostaglandin F1 alpha Eicosanoids Masoprocol Dose-Response Relationship, Drug Double-Blind Method Butanones Rats, Sprague-Dawley Adverse Drug Reaction Reporting Systems Piroxicam Thromboxane A2 Intramolecular Oxidoreductases Gastric Mucosa Acetaminophen Thromboxane-A Synthase Enzyme Inhibitors Arachidonate 5-Lipoxygenase Furans Thromboxanes Meclofenamic Acid Hydroxyeicosatetraenoic Acids Phenacetin Leukotriene B4 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid Jurisprudence Prostaglandins G Seminal Vesicles 5,8,11,14-Eicosatetraynoic Acid Dinoprost 2-Aminoadipic Acid Desmosine 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine Rats, Wistar Isoxazoles RNA, Messenger Endothelium, Vascular Early Termination of Clinical Trials Edema Prostaglandins E Vasodilation Nitric Oxide Elastin Peptic Ulcer Nitric Oxide Synthase Blood Platelets Otorhinolaryngologic Surgical Procedures Phospholipases A Prostaglandin H2 Phospholipases A2 Arthralgia Enzyme Induction Drug Interactions Duodenal Obstruction Gene Expression Regulation, Enzymologic Sulindac Drug Utilization Review Cells, Cultured Leukotrienes 8,11,14-Eicosatrienoic Acid Ketorolac Placebos Product Surveillance, Postmarketing Vasoconstriction Anti-Inflammatory Agents Chromatography, High Pressure Liquid

No FAQ available that match "rofecoxib cyclooxygenase 2 inhibitors"